A Multi-Center, Randomized, Double-Blind Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor (The MVP Study).

Trial Profile

A Multi-Center, Randomized, Double-Blind Phase III Study of the Efficacy and Safety of the Misoprostol Vaginal Insert Compared to Cervidil for Women Requiring Cervical Ripening and Induction of Labor (The MVP Study).

Completed
Phase of Trial: Phase III

Latest Information Update: 22 Jun 2012

At a glance

  • Drugs Dinoprostone; Misoprostol
  • Indications Labour disorders; Labour induction
  • Focus Therapeutic Use
  • Acronyms MVP
  • Most Recent Events

    • 01 Oct 2008 Results have been published in Obstetrics and Gynecology.
    • 10 Sep 2007 Status changed from recruiting to completed.
    • 12 Jun 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top